+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
ASTEC

Astec Lifesciences Share Price

₹602.95 -40.55 (-6.3%)
35.98% Fall from 52W High

28 Oct, 2026 3:31 PM (IST)

Astec Lifesciences live price: ₹602.95. It opened at ₹645 vs previous close ₹644; intraday high/low: ₹664/₹596. The 50 & 200 DMA stand at ₹680.80/₹691.30.

Astec Lifesciences Performance

  • Today's Low
  • ₹596
  • Today's High
  • ₹664
  • 52 Week Low
  • ₹513
  • 52 Week High
  • ₹942
  • Open Price₹645
  • Previous Close₹644
  • Volume117,699
  • 50 DMA₹680.80
  • 100 DMA₹678.70
  • 200 DMA₹691.30

Astec Lifesciences Chart

Investment Returns

  • Over 1 Month -18.41%
  • Over 3 Month -9.28%
  • Over 6 Month -19.6%
  • Over 1 Year -8.62%

Smart Investing Starts Here Start SIP with Astec Lifesciences for Steady Growth!

Invest Now

Astec Lifesciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -16.9
  • PEG Ratio
  • -0.6
  • Market Cap Cr
  • 1,344
  • P/B Ratio
  • 3.6
  • Average True Range
  • 43.6
  • EPS
  • -35.7
  • Dividend Yield
  • 0
  • MACD Signal
  • -13.4
  • RSI
  • 32.94
  • MFI
  • 23.1

Latest Stock News Updates

Astec Lifesciences Ltd - 533138 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find enclosed, newspaper publication of Financial Results for the Quarter and Half Year ended September 30, 2026.

Astec Lifesciences Ltd - 533138 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Please find attached Press Release

Q2FY27 Quarterly Result Announced for Astec Lifesciences Ltd.

<h3><span style="font-size:16px;"><strong>Agrochemicals company Astec Lifesciences announced Q2FY27 results</strong></span></h3> <p><strong>Standalone Financial Highlights:</strong><!--TgQPHd|||[[2,[null,null,null,null,null,null,null,null,null,null,null,null,[351768,null,0]],[],null,1]]--></p> <ul data-complete="true" data-hveid="CAAICRAA" data-processed="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="wiLEJc#NS0kde" jsuid="gA2uv_1c"> <li data-complete="true" data-hveid="CAAICRAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gA2uv_1d"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gA2uv_1f">Revenue from Operations<!--TgQPHd|||[]--></strong> stood at Rs 7,202.01 lakh in Q2FY27, recording a YoY decrease of 2.31% from Rs 7,372.06 lakh in Q2FY26 and a sequential decline of 13.81% compared to Rs 8,356.43 lakh in Q1FY27. For H1FY27, standalone revenue from operations reached Rs 15,558.44 lakh, marking a 5.59% drop from Rs 16,480.27 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICRAH" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gA2uv_1t"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gA2uv_1v">Total Income<!--TgQPHd|||[]--></strong> stood at Rs 7,261.73 lakh in Q2FY27, registering a contraction of 2.94% YoY over Rs 7,481.50 lakh in Q2FY26 and dropping 13.83% QoQ relative to Rs 8,427.28 lakh in Q1FY27. For H1FY27, standalone total income reached Rs 15,689.01 lakh, sliding 5.71% YoY from Rs 16,638.37 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICRAK" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gA2uv_21"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gA2uv_23">Profit Before Tax (PBT)<!--TgQPHd|||[]--></strong> (reported as Loss Before Tax) landed at a negative Rs 3,746.96 lakh in Q2FY27, widening significantly from a loss of Rs 2,445.09 lakh in Q2FY26 (a 53.24% loss expansion YoY) and expanding by 99.53% QoQ against a loss of Rs 1,877.92 lakh in Q1FY27. Standalone H1FY27 loss before tax was established at Rs 5,624.88 lakh, down 2.18% over a loss of Rs 5,750.73 lakh noted in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICRAN" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gA2uv_29"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gA2uv_2b">Profit After Tax (PAT)<!--TgQPHd|||[]--></strong> (reported as Loss For the Period) recorded a negative Rs 3,742.88 lakh in Q2FY27, widening by 53.07% YoY over a loss of Rs 2,445.09 lakh in Q2FY26 and expanding by 99.74% sequentially against a loss of Rs 1,873.84 lakh in Q1FY27. Standalone H1FY27 loss after tax came in at Rs 5,616.72 lakh, showing a small compression of 2.33% over a loss of Rs 5,750.73 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICRAQ" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gA2uv_2h"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gA2uv_2j">Earnings Per Share (EPS)<!--TgQPHd|||[]--></strong> basic and diluted arrived at a negative Rs 16.80 in Q2FY27, representing a 47.50% loss increase YoY from a negative Rs 11.39 in Q2FY26 and a 99.76% loss expansion sequentially over a negative Rs 8.41 in Q1FY27. For H1FY27, basic and diluted standalone EPS came in at a negative Rs 25.21, narrowing its loss framework by 9.93% against a negative Rs 27.99 in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <!--TgQPHd|||[]--> </ul> <p><!--TgQPHd|||[]--></p> <p><strong>Consolidated Financial Highlights:</strong><!--TgQPHd|||[[2,[null,null,null,null,null,null,null,null,null,null,null,null,[351768,null,0]],[],null,1]]--></p> <ul data-complete="true" data-hveid="CAAICxAA" data-processed="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="wiLEJc#NS0kde" jsuid="gA2uv_2r"> <li data-complete="true" data-hveid="CAAICxAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gA2uv_2s"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gA2uv_2u">Revenue From Operations<!--TgQPHd|||[]--></strong> stood at Rs 7,202.01 lakh in Q2FY27, tracking a YoY reduction of 2.31% over Rs 7,372.06 lakh in Q2FY26 alongside a QoQ drop of 13.81% from Rs 8,356.43 lakh in Q1FY27. For H1FY27, consolidated revenue from operations aggregated to Rs 15,558.44 lakh, descending by 5.59% relative to Rs 16,480.27 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICxAD" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gA2uv_2y"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gA2uv_30">Total Income<!--TgQPHd|||[]--></strong> arrived at Rs 7,263.64 lakh in Q2FY27, representing a YoY slip of 2.94% from Rs 7,483.62 lakh in Q2FY26 and tracking an 13.83% sequential fall from Rs 8,429.17 lakh in Q1FY27. Consolidated total income for H1FY27 reached Rs 15,692.81 lakh, decreasing by 5.71% YoY over Rs 16,642.48 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICxAE" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gA2uv_31"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gA2uv_33">Profit Before Tax (PBT)<!--TgQPHd|||[]--></strong> (reported as Loss Before Tax) landed at a negative Rs 3,742.78 lakh in Q2FY27, widening by 53.35% YoY relative to a loss of Rs 2,440.74 lakh in Q2FY26 and expanding by 99.74% QoQ against a loss of Rs 1,873.82 lakh in Q1FY27. Consolidated H1FY27 loss before tax was posted at Rs 5,616.60 lakh, narrowing by 2.19% YoY compared to a loss of Rs 5,742.49 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICxAF" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gA2uv_34"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gA2uv_36">Profit After Tax (PAT)<!--TgQPHd|||[]--></strong> (reported as Loss For the Period) came in at a negative Rs 3,739.71 lakh in Q2FY27, expanding its loss position by 53.16% YoY from a loss of Rs 2,441.70 lakh in Q2FY26 and scaling up by 99.91% QoQ compared to a loss of Rs 1,870.73 lakh in Q1FY27. Consolidated H1FY27 loss after tax logged Rs 5,610.44 lakh, decreasing by 2.33% YoY relative to a loss of Rs 5,744.39 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICxAG" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gA2uv_37"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gA2uv_39">Earnings Per Share (EPS)<!--TgQPHd|||[]--></strong> basic and diluted was established at a negative Rs 16.79 in Q2FY27, representing a 47.93% loss expansion YoY over a negative Rs 11.35 in Q2FY26 and a 99.88% loss spike sequentially over a negative Rs 8.40 in Q1FY27. For H1FY27, basic and diluted consolidated EPS arrived at a negative Rs 25.19, reflecting a 9.94% loss reduction versus a negative Rs 27.97 in H1FY26.</li> </ul> <p><a class="lb" href="/get-document/post/pdf/5910662/" target="_blank">Result PDF</a></p>

Astec Lifesciences Financials

Astec Lifesciences Technicals

EMA & SMA

Current Price
₹602.95
-40.55 (-6.3%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹682.00
  • 50 Day
  • ₹680.80
  • 100 Day
  • ₹678.70
  • 200 Day
  • ₹691.30

Resistance and Support

620.72 Pivot Speed
  • R3 713.50
  • R2 688.50
  • R1 645.70
  • S1 577.90
  • S2 552.90
  • S3 510.10

Astec Lifesciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-10-26 Quarterly Results
2026-07-31 Quarterly Results
2026-04-27 Audited Results
2026-01-30 Quarterly Results
2025-10-29 Quarterly Results

Astec Lifesciences Shareholding Pattern

71.96%
24.67%
3.02%
0.32%
0.02%

About Astec Lifesciences

Astec Lifesciences manufactures a wide range of Agrochemical active ingredients and pharmaceutical intermediates. View More
  • NSE Symbol
  • ASTEC
  • BSE Symbol
  • 533138
  • ISIN
  • INE563J01010

Similar Stocks to Astec Lifesciences

Astec Lifesciences FAQs

Astec Lifesciences share price is ₹602 As on 28 October, 2026 | 20:53

The Market Cap of Astec Lifesciences is ₹1343.5 Cr As on 28 October, 2026 | 20:53

The P/E ratio of Astec Lifesciences is -16.9 As on 28 October, 2026 | 20:53

The PB ratio of Astec Lifesciences is 3.6 As on 28 October, 2026 | 20:53

The 52 week High & Low of Astec Lifesciences is ₹941.8/₹513.4 respectively As on 28 October, 2026 | 20:53

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23